AACC Annual Meeting and Clinical Lab Expo 2013 Logo

Spotlight on Science

Abstracts selected by the Annual Meeting Organizing Committee with assistance from the National Academy of Clinical Biochemistry for their quality and the importance of their research in one of three topic areas will be presented in dynamic sessions held on three consecutive afternoons. In each 15-minute presentation and 5-minute question-and-answer session, attendees will hear the best of cutting-edge research, a hallmark of the AACC Annual Meeting.


Chronic Diseases and Clinical Outcomes

July 29, 2:30–5 p.m.

Review of Ordering Practices for Procalcitonin From a Critical Care Unit

Douglas Stickle, PhD, BS, MS, DABCC

Thomas Jefferson University Jefferson Medical College, Philadelphia

Determination of Cardiac Troponin With a Single-Molecule High Sensitivity Assay and Outcomes in Patients With Stable Coronary Artery Disease: Analysis From PROVE IT-TIMI 22

Petr Jarolim, MD, PhD

Brigham and Women’s Hospital, Boston

Procalcitonin as a Biomarker of Bacterial Infection in Acute Liver Failure

Jody A. Balko, MS

University of Texas Southwestern

Medical Center, Dallas

Measurement of Galectin-3 Levels with the Architect Assay in Patients with Systolic Heart Failure

Damien Gruson, PharmD Cliniques Universitaires Saint-Luc

Brussels, Belgium

Plasma Levels of D-Dimer as an Indicator of Severity and Mortality in Acute Stroke: Application of Biochip Array Kit

Craig Ledgerwood, PhD Randox Laboratories Limited

Crumlim, Northern Ireland

Performance of a High-Sensitivity Cardiac Troponin I Assay in Patients With Non-ST-Elevation Acute Coronary Syndrome

Petr Jarolim, MD, PhD

Brigham and Women's Hospital, Boston

Absence of Association Between Serum Folate and the Development of Preeclampsia in Women Exposed to Folic Acid Supplementation and Food Fortification Sebastien Theruault, MD

Universite Laval, Quebec City, Canada


Personalized and Translational Medicine

July 30, 2:30–5 p.m.

The CYP1A2*1D Polymorphism Has a Significant Impact on Olanzapine Serum Concentrations

Werner Steimer, MD, FACB Technical University of Munich

Munich, Germany

Rapid and Cost Effective Measurement of Circulating Cell Free Graft DNA for the Early Detection of Liver Transplant Ekkehard Schuetz, MD

University of Göttingen

Göttingen, Germany

The Association of a Single Nucleotide Polymorphism in FSHR Gene With Adverse Radiotherapeutic Effects in Prostate Cancer Patients Zengliu Su, MD

Medical University of South Carolina


Biological Variation and Quality Specifications for 38 Biochemical Markers in a Pediatric Population

Victoria Bevilacqua, BS

The Hospital for Sick Children

Toronto, Canada

Establishing Analytical Methods for CYP2D6 Genotyping and Measurement of Tamoxifen and Its Metabolites for the Assessment of Tamoxifen Therapy


Sunnybrook Health Science Center

Toronto, Canada

PSA Enzymatic Activity: A New Biomarker for Assessing Prostate Cancer Aggressiveness

Dimitra Georganopoulou, PhD

OHMX Corporation, Evanston, Ill.

A Highly Sensitive and Specific Method for Characterization of Circulating Tumor Cell Subtypes in Breast Cancer Patients

Lori Millner, PhD

University of Louisville Health

Sciences Center, Louisville, Ky.


Clinical Implementation of Emerging Technologies

July 31, 2:30–5 p.m.

On-Site Colorimetric Detection of Sweat Chloride Ion for Diagnosing Cystic Fibrosis

Xuan Mu, PhD

Peking Union Medical College

Beijing, China

Prostate Proteins Glycosylation Profile and Its Potential as a Diagnostic Biomarker for Prostate Cancer

Joris Delanghe, PhD, MD

University Hospital Ghent

Ghent, Belgium

Use of Urinary Neutrophil Gelatinase-Associated Lipocalin in the Diagnosis of Acute Kidney Injury Among Stroke Patients. Is It Time to Rethink Our Diagnostic Criteria for AKI?

Konstantinos Makris, PhD

KAT General Hospital, Athens, Greece

Identification of Models to Predict Sepsis in Emergency Department Patients

Frances Cate, MD

Vanderbilt University, Nashville, Tenn.

Predicting Iron Deficiency From Complete Blood Counts Using a Mathematical Model of RBC Maturation

Harsh Patel, BS

Massachusetts General Hospital, Boston

BCMA Is a Novel Serum Biomarker for Diagnosis and Prognosis of Multiple Myeloma

Haiming Chen, MD, PhD

Institute for Myeloma and Bone Cancer Research

West Hollywood, Calif.

Identification of Novel Biomarkers of Hemorrhagic Stroke by Integrating Bioinformatic and Mass Spectrometry-Based Approaches

Eduardo Martinez, PhD

Mt. Sinai Hospital, Toronto, Canada